Growth differentiation factor 11: A new hope for the treatment of cardiovascular diseases

被引：3

作者：

Shao, Yingchun ^{[1
]}

Wang, Yanhong ^{[1
]}

Xu, Jiazhen ^{[1
]}

Yuan, Yang ^{[1
]}

Xing, Dongming ^{[1
,2
,3
]}

机构：

[1] Qingdao Univ, Affiliated Hosp, Qingdao Canc Inst, Qingdao 266071, Peoples R China

[2] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China

[3] Qingdao Univ, Affiliated Hosp, Qingdao 266071, Peoples R China

来源：

CYTOKINE & GROWTH FACTOR REVIEWS | 2023年 / 71-72卷

关键词：

Growth differentiation factor 11; GDF11; Myocardial injury; Cardiovascular diseases; Apoptosis; SKELETAL-MUSCLE; CELL DIFFERENTIATION; STEM-CELLS; GDF11; EXPRESSION; MYOSTATIN; INJURY; AGE; PROLIFERATION; NEUROGENESIS;

D O I：

10.1016/j.cytogfr.2023.06.007

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Growth differentiation factor 11 (GDF11) is a member of the transforming growth factor-& beta; superfamily that has garnered significant attention due to its anti-cardiac aging properties. Many studies have revealed that GDF11 plays an indispensable role in the onset of cardiovascular diseases (CVDs). Consequently, it has emerged as a potential target and novel therapeutic agent for CVD treatment. However, currently, no literature reviews comprehensively summarize the research on GDF11 in the context of CVDs. Therefore, herein, we comprehen-sively described GDF11's structure, function, and signaling in various tissues. Furthermore, we focused on the latest findings concerning its involvement in CVD development and its potential for clinical translation as a CVD treatment. We aim to provide a theoretical basis for the prospects and future research directions of the GDF11 application regarding CVDs.

引用

页码：82 / 93

页数：12

共 50 条

[41] Growth differentiation factor 15: Emerging role in liver diseases
Li, Yu
Zhang, Jie
Chen, Shurong
Ke, Yini
Li, Youming
Chen, Yi
CYTOKINE, 2024, 182
[42] Treatment hope for prion diseases
Le Page, Michael
NEW SCIENTIST, 2023, 246 (3443) : 10 - 10
[43] Expression of growth/differentiation factor 11, a new member of the BMP/TGFβ superfamily during mouse embryogenesis
Nakashima, M
Toyono, T
Akamine, A
Joyner, A
MECHANISMS OF DEVELOPMENT, 1999, 80 (02) : 185 - 189
[44] Doctor inertness as a factor disturbing effective treatment of cardiovascular diseases
Minakov, E. V.
Khokhlov, R. A.
Furmenko, G. I.
Akhmedzhanov, N. M.
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2009, 5 (02) : 39 - 48
[45] GROWTH DIFFERENTIATION FACTOR-15 AND CARDIOVASCULAR DISEASE IN THALASSEMIA INTERMEDIA
Tantawy, A.
Adly, A. A.
Ismail, E.
Yousef, O.
Ali, M.
HAEMATOLOGICA, 2015, 100 : 598 - 598
[46] Nerve growth factor (NGF) for the treatment of diabetic neuropathy. Is there hope?
Quasthoff, S
Hartung, HP
NERVENARZT, 2001, 72 (06): : 456 - 459
[47] New technologies for the diagnosis, treatment, and monitoring of cardiovascular diseases
Rubio, Lorenzo Facila
Lozano-Granero, Cristina
Vidal-Perez, Rafael
Barrios, Vivencio
Freixa-Pamias, Roman
REVISTA ESPANOLA DE CARDIOLOGIA, 2024, 77 (01): : 88 - 96
[48] MACORVIS - A NEW OPPORTUNITY FOR ADDITION TO THE TREATMENT OF CARDIOVASCULAR DISEASES
Kaloyan, Kaloyanov
INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (11): : 4169 - 4172
[49] Adherence to the treatment of chronic cardiovascular diseases: new solutions
Borghi, Claudio
Desideri, Giovambattista
Tocci, Giuliano
Trimarco, Bruno
Nati, Giulio
GIORNALE ITALIANO DI CARDIOLOGIA, 2021, 22 (05) : E86 - E91
[50] Circulating Growth Differentiation Factor 11/8 Levels Decline With Age
Poggioli, Tommaso
Vujic, Ana
Yang, Peiguo
Macias-Trevino, Claudio
Uygur, Aysu
Loffredo, Francesco S.
Pancoast, James R.
Cho, Miook
Goldstein, Jill
Tandias, Rachel M.
Gonzalez, Emilia
Walker, Ryan G.
Thompson, Thomas B.
Wagers, Amy J.
Fong, Yick W.
Lee, Richard T.
CIRCULATION RESEARCH, 2016, 118 (01) : 29 - 37

← 1 2 3 4 5 →